Location History:
- Avondale, NZ (2002)
- Auckland, NZ (2001 - 2014)
- Waitakere, NZ (2014 - 2015)
Company Filing History:
7 out of 28 
3 out of 5 
1 out of 250 
Years Active: 2001-2025
Title: Inventor Jian Guan: Innovations in Disease Management and Cognitive Performance
Introduction
Jian Guan, an accomplished inventor based in Auckland, New Zealand, has made significant contributions to the field of biomedical innovations. With a portfolio of 12 patents, he has been at the forefront of developing methods and treatments aimed at addressing various non-neurological and neurological conditions.
Latest Patents
One of Jian Guan's latest patents focuses on IGF-1 analysis, adjustment, and disease management of both non-neurological and neurological conditions. This invention describes improvements in how IGF-1 functions are analyzed and adjusted clinically, particularly through the application of cyclic glycine-proline (cGP) as a biomarker. The methods outlined allow for improved prediction of risk and recovery related to IGF-1 dysfunction. In addition, this invention emphasizes the use of cGP derived from organic or plant-based materials, such as concentrated extracts of blackcurrant anthocyanins, for effective treatment.
Another groundbreaking patent from Jian Guan revolves around Cyclic Glycyl-2-Allyl Proline, which aims to enhance cognitive performance in impaired animals. This patent includes methods for the therapeutic use of this compound to address cognitive disorders and details the manufacturing processes for medicaments, such as tablets, capsules, and injectable solutions designed for effective treatment.
Career Highlights
Throughout his career, Jian Guan has worked with notable companies in the pharmaceutical field, including Neuren Pharmaceuticals Limited and Neuronz Limited. His expertise in developing innovative solutions for medical challenges has positioned him as a key figure in his industry.
Collaborations
Jian Guan has collaborated with respected colleagues in the medical and scientific community, including Peter David Gluckman and Margaret Anne Brimble. These partnerships have furthered his research efforts and the practical application of his patents.
Conclusion
In summary, Jian Guan stands out as a significant inventor, with a proven track record of innovative contributions to healthcare. His latest patents, focusing on IGF-1 and cognitive performance, reflect his commitment to advancing treatment options for neurological and non-neurological conditions. As he continues to develop new methods and collaborate with other experts, his work promises to bring valuable improvements to the medical field.